Insider
Date
Role
Action
Shares
Price
Amount
Douglas Love
24 Sep 2026
President and CEO
Buy
26,065
$3.83
$99.83K
Ted Yednock
11 Jun 2026
EVP & Chief Innovation Officer
Exercised, kept
30,646
$1.85
$56.70K
Muneer A Satter
28 May 2026
Director
Buy
indirect
613,497
$5.41
$3.32M
William H. Carson
11 May 2026
Director
Buy
8,000
$5.78
$46.24K
William H. Carson
10 Apr 2026
Director
Buy
8,000
$6.20
$49.60K
William H. Carson
10 Mar 2026
Director
Buy
8,000
$5.67
$45.36K
Jennifer Lew
2 Mar 2026
EVP & Chief Financial Officer
Sell
5,565
$5.42
$30.16K
Dean Richard Artis
2 Mar 2026
EVP & Chief Scientific Officer
Sell
5,894
$5.43
$32.00K
Ted Yednock
2 Mar 2026
EVP & Chief Innovation Officer
Sell
5,566
$5.42
$30.17K
Michael Overdorf
2 Mar 2026
EVP & Chief Business Officer
Sell
4,339
$5.42
$23.52K
Jamie Dananberg
2 Mar 2026
Chief Medical Officer
Sell
5,820
$5.43
$31.60K
Michael Overdorf
18 Feb 2026
EVP & Chief Business Officer
Sell
6,225
$5.10
$31.75K
Ted Yednock
18 Feb 2026
EVP & Chief Innovation Officer
Sell
7,857
$5.11
$40.15K
Dean Richard Artis
18 Feb 2026
EVP & Chief Scientific Officer
Sell
5,290
$5.10
$26.98K
Jennifer Lew
18 Feb 2026
EVP & Chief Financial Officer
Sell
7,851
$5.11
$40.12K
Jamie Dananberg
18 Feb 2026
Chief Medical Officer
Sell
5,290
$5.10
$26.98K
William H. Carson
30 Dec 2025
Director
Buy
4,115
$5.02
$20.66K
William H. Carson
1 Dec 2025
Director
Buy
4,115
$4.47
$18.39K
Jung Choi
1 Dec 2025
Director
Buy
indirect
33,000
$4.19
$138.27K
Muneer A Satter
21 Nov 2025
Director
Buy
indirect
422,613
$4.28
$1.81M
Muneer A Satter
20 Nov 2025
Director
Buy
indirect
400,000
$4.48
$1.79M
Muneer A Satter
19 Nov 2025
Director
Buy
indirect
500,000
$3.94
$1.97M
Muneer A Satter
18 Nov 2025
Director
Buy
indirect
500,000
$3.18
$1.59M
Muneer A Satter
17 Nov 2025
Director
Buy
indirect
500,000
$2.99
$1.50M
William H. Carson
30 Oct 2025
Director
Buy
4,115
$3.17
$13.04K
William H. Carson
30 Sep 2025
Director
Buy
4,115
$3.05
$12.55K
William H. Carson
2 Sep 2025
Director
Buy
4,115
$2.09
$8.60K
William H. Carson
30 Jul 2025
Director
Buy
4,115
$2.43
$10.00K
Michael Overdorf
14 Jul 2025
EVP & Chief Business Officer
Sell
853
$2.61
$2.23K
Jennifer Lew
14 Jul 2025
EVP & Chief Financial Officer
Sell
1,117
$2.58
$2.88K
Ted Yednock
14 Jul 2025
EVP & Chief Innovation Officer
Sell
1,116
$2.58
$2.88K
William H. Carson
30 Jun 2025
Director
Buy
4,115
$2.46
$10.12K
Jennifer Lew
18 Feb 2025
EVP & Chief Financial Officer
Sell
6,912
$2.92
$20.18K
Michael Overdorf
18 Feb 2025
EVP & Chief Business Officer
Sell
6,618
$2.95
$19.52K
Ted Yednock
18 Feb 2025
EVP & Chief Innovation Officer
Sell
8,345
$2.91
$24.28K
Dean Richard Artis
18 Feb 2025
EVP & Chief Scientific Officer
Sell
5,515
$2.97
$16.38K
Jamie Dananberg
18 Feb 2025
Chief Medical Officer
Sell
5,521
$2.96
$16.34K
Ted Yednock
13 Feb 2025
EVP & Chief Innovation Officer
Sell
1,783
$2.99
$5.33K
Michael Overdorf
13 Feb 2025
EVP & Chief Business Officer
Sell
1,425
$2.99
$4.26K
Jennifer Lew
13 Feb 2025
EVP & Chief Financial Officer
Sell
1,786
$2.98
$5.32K
Douglas Love
13 Feb 2025
President and CEO
Sell
5,021
$2.95
$14.81K
Douglas Love
6 Jan 2025
President and CEO
Exercised, kept
37,994
$1.41
$53.56K
William H. Carson
2 Dec 2024
Director
Buy
3,200
$5.33
$17.06K
Douglas Love
30 Oct 2024
President and CEO
Exercised, kept
36,050
$1.85
$66.70K
Douglas Love
30 Oct 2024
President and CEO
Exercised, kept
78,399
$1.85
$145.05K
Ted Yednock
15 Oct 2024
EVP & Chief Innovation Officer
Sold after exercise
5,408
$7.41
$40.07K
William H. Carson
1 Oct 2024
Director
Buy
3,200
$5.97
$19.10K
Ted Yednock
19 Sep 2024
EVP & Chief Innovation Officer
Sold on a plan
indirect
4,500
$7.10
$31.95K
Ted Yednock
12 Sep 2024
EVP & Chief Innovation Officer
Sold on a plan
indirect
5,500
$6.16
$33.88K
Ted Yednock
5 Sep 2024
EVP & Chief Innovation Officer
Sold on a plan
indirect
5,500
$5.64
$31.02K
William H. Carson
3 Sep 2024
Director
Buy
3,200
$5.48
$17.54K
Ted Yednock
29 Aug 2024
EVP & Chief Innovation Officer
Sold on a plan
indirect
5,500
$5.95
$32.73K
William H. Carson
1 Aug 2024
Director
Buy
3,200
$6.24
$19.97K
Ted Yednock
15 Jul 2024
EVP & Chief Innovation Officer
Sell
1,106
$6.02
$6.66K
Jennifer Lew
15 Jul 2024
EVP & Chief Financial Officer
Sell
1,104
$6.03
$6.66K
Michael Overdorf
15 Jul 2024
EVP & Chief Business Officer
Sell
784
$6.02
$4.72K
William H. Carson
1 Jul 2024
Director
Buy
3,200
$5.00
$16.00K
William H. Carson
3 Jun 2024
Director
Buy
3,200
$4.83
$15.46K
William H. Carson
1 May 2024
Director
Buy
3,200
$4.68
$14.98K
William H. Carson
8 Apr 2024
Director
Buy
3,200
$6.07
$19.41K
Michael Overdorf
20 Feb 2024
EVP & Chief Business Officer
Sell
1,951
$5.48
$10.69K
Ted Yednock
20 Feb 2024
EVP & Chief Innovation Officer
Sell
2,604
$5.51
$14.35K
Jennifer Lew
20 Feb 2024
EVP & Chief Financial Officer
Sell
2,593
$5.53
$14.34K
Ted Yednock
12 Feb 2024
EVP & Chief Innovation Officer
Sell
1,810
$5.54
$10.03K
Jennifer Lew
12 Feb 2024
EVP & Chief Financial Officer
Sell
1,809
$5.54
$10.02K
Douglas Love
12 Feb 2024
President and CEO
Sell
5,782
$5.54
$32.03K
Michael Overdorf
12 Feb 2024
EVP & Chief Business Officer
Sell
1,349
$5.53
$7.46K
Ted Yednock
27 Dec 2023
EVP & Chief Innovation Officer
Sold after exercise
21,000
$4.52
$94.97K
Muneer A Satter
26 Dec 2023
Director
Buy
indirect
350,000
$2.88
$1.01M
Jennifer Lew
11 Jul 2023
EVP & Chief Financial Officer
Sell
1,057
$3.84
$4.05K
Michael Overdorf
11 Jul 2023
EVP & Chief Business Officer
Sell
978
$3.84
$3.75K
Bain Capital Life Sciences Investors, LLC
25 May 2023
10% owner
Buy
indirect
300,000
$2.13
$639.72K
Douglas Love
15 Feb 2023
President & CEO
Sell
6,571
$5.87
$38.56K
Jennifer Lew
14 Feb 2023
EVP & Chief Financial Officer
Sell
166
$6.30
$1.05K
Michael Overdorf
14 Feb 2023
EVP & Chief Business Officer
Sell
144
$6.30
$907.10
Jennifer Lew
13 Feb 2023
EVP & Chief Financial Officer
Sell
1,742
$6.31
$10.99K
Michael Overdorf
13 Feb 2023
EVP & Chief Business Officer
Sell
1,501
$6.30
$9.46K
Muneer A Satter
10 Feb 2023
Director
Buy
indirect
2,647,058
$6.80
$18.00M
Muneer A Satter
7 Jul 2022
Director
Buy
indirect
2,453,988
$3.84
$9.42M
Douglas Love
14 Apr 2022
President & CEO
Buy
60,000
$2.45
$146.81K
Douglas Love
11 Nov 2021
President & CEO
Exercised, kept
30,000
$1.85
$55.50K
Douglas Love
11 Nov 2021
President & CEO
Exercised, kept
70,942
$1.41
$100.00K
Douglas Love
16 Sep 2021
President & CEO
Sold after exercise
7,500
$22.05
$165.34K
Jennifer Lew
13 Sep 2021
EVP & Chief Financial Officer
Sold after exercise
3,500
$20.01
$70.03K
Ted Yednock
13 Sep 2021
EVP & Chief Scientific Officer
Sold after exercise
16,190
$20.00
$323.86K
Douglas Love
8 Jun 2021
President & CEO
Sold after exercise
3,750
$22.55
$84.56K
Douglas Love
7 Jun 2021
President & CEO
Sold after exercise
3,750
$22.31
$83.67K
Ted Yednock
3 Jun 2021
EVP & Chief Scientific Officer
Sold after exercise
2,184
$21.72
$47.44K
Ted Yednock
3 Jun 2021
EVP & Chief Scientific Officer
Sold after exercise
12,816
$21.45
$274.88K
Jennifer Lew
27 May 2021
EVP & Chief Financial Officer
Sold after exercise
3,500
$22.24
$77.84K
Douglas Love
1 Apr 2021
President & CEO
Sold after exercise
300
$28.01
$8.40K
Douglas Love
1 Apr 2021
President & CEO
Sold after exercise
200
$28.19
$5.64K
Douglas Love
31 Mar 2021
President & CEO
Sold after exercise
7,102
$28.11
$199.62K
Douglas Love
30 Mar 2021
President & CEO
Sold after exercise
1,850
$24.78
$45.85K
Douglas Love
30 Mar 2021
President & CEO
Sold after exercise
1,900
$24.27
$46.12K
Douglas Love
29 Mar 2021
President & CEO
Sold after exercise
300
$27.24
$8.17K
Douglas Love
29 Mar 2021
President & CEO
Sold after exercise
600
$26.42
$15.85K
Douglas Love
29 Mar 2021
President & CEO
Sold after exercise
2,850
$25.02
$71.31K
Ted Yednock
25 Mar 2021
EVP & Chief Scientific Officer
Sold after exercise
237
$29.96
$7.10K
Ted Yednock
25 Mar 2021
EVP & Chief Scientific Officer
Sold after exercise
5,680
$29.21
$165.91K
Ted Yednock
25 Mar 2021
EVP & Chief Scientific Officer
Sold after exercise
10,258
$28.54
$292.76K
Sanjay Chandru Keswani
24 Mar 2021
EVP & Chief Medical Officer
Sold after exercise
3,995
$30.17
$120.51K
Jennifer Lew
23 Mar 2021
EVP & Chief Financial Officer
Sold after exercise
1,800
$29.16
$52.49K
Jennifer Lew
23 Mar 2021
EVP & Chief Financial Officer
Sold after exercise
1,800
$28.43
$51.17K
Jennifer Lew
23 Mar 2021
EVP & Chief Financial Officer
Sold after exercise
1,400
$27.51
$38.51K
James E Flynn
28 Jul 2020
10% owner
Buy
indirect
350,000
$17.00
$5.95M
James E Flynn
28 Jul 2020
10% owner
Buy
indirect
350,000
$17.00
$5.95M
Muneer A Satter
28 Jul 2020
Director
Buy
indirect
200,000
$17.00
$3.40M
Jennifer Lew
28 Jul 2020
EVP & Chief Financial Officer
Buy
2,000
$17.00
$34.00K
Bain Capital Life Sciences Investors, LLC
28 Jul 2020
10% owner
Buy
indirect
400,000
$17.00
$6.80M
Clarus Lifesciences III, L.P.
28 Jul 2020
10% owner
Buy
indirect
200,000
$17.00
$3.40M
